In 2024, Medicaid providers in Kenilworth billed $1,321,316 for Pathology and Laboratory Procedures services, data from the U.S. Department of Health and Human Services Medicaid Provider Spending database show. This amount was an 18.1% increase compared to 2023, when $1,119,212 in claims were filed for the same service type.
Medicaid operates as a public health insurance program administered by states and funded through a partnership of federal and state governments. It provides coverage to people with low incomes, families, seniors, children, and people with disabilities, making it a major segment of the nation’s health care system.
Shifts in local Medicaid billing amounts reflect how taxpayer-funded health dollars are disbursed within a community.
The “Pathology and Laboratory Procedures” grouping includes Medicaid-billed services organized according to standardized HCPCS and CPT code sets. For this analysis, each billing code was placed into a single service group using common code prefixes and numbering, facilitating an examination of related services without double counting and supporting accurate tracking year to year.
Pathology and Laboratory Procedures received more Medicaid payments than any other category in Kenilworth in 2024.
At the state level, Pathology and Laboratory Procedures placed sixth among all Medicaid payment categories in New Jersey in 2024.
In the five years ending in 2024, Medicaid payments associated with the Pathology and Laboratory Procedures category in Kenilworth climbed by $3,159,238, or 70.5%. Certain intervals saw accelerated increases, with significant year-over-year growth in 2023 and 2022.
While distribution of Medicaid spending on Pathology and Laboratory Procedures spanned the city, the majority was concentrated in a few ZIP codes. In 2024, ZIP code 07033 recorded $1,321,315 in related Medicaid payments—accounting for 100% of Kenilworth’s total for this category that year.
Within this category, Medicaid expenditures were also focused among a select group of billing codes.
For comparison, spending in the Pathology and Laboratory Procedures category in Kenilworth rose by 18.1% between 2024 and 2023, whereas overall Medicaid claims in the city increased by 0.6% during the same period.
The Centers for Medicare & Medicaid Services report indicates that total joint federal and state Medicaid expenditures reached about $871.7 billion in fiscal year 2023, constituting about 18% of all U.S. health expenses and significantly up from roughly $613.5 billion in 2019 before the COVID-19 pandemic.
This amount marks a nearly 40% increase in just a few years, largely due to higher enrollment and increased utilization during and after the pandemic.
Recent federal budget measures introduced during the Trump administration featured substantial proposals to reduce Medicaid funding and change program structures. The “One Big Beautiful Bill Act,” signed in 2025, is projected to cut federal Medicaid spending by over $1 trillion over the next decade. It brings new policies such as work requirements and higher cost-sharing, which could limit eligibility or funding for some recipients. This approach may shift more Medicaid costs to states and could constrain growth of federal support as Medicaid continues to serve tens of millions of Americans.
| Year | Total Medicaid Payments | % Change From Previous Year |
|---|---|---|
| 2020 | $4,480,553 | -32.5% |
| 2021 | $4,021,690 | -10.2% |
| 2022 | $3,604,155 | -10.4% |
| 2023 | $1,119,211 | -68.9% |
| 2024 | $1,321,315 | 18.1% |
| Rank | Category | Medicaid Payments | Share of City Total |
|---|---|---|---|
| 1 | Pathology and Laboratory Procedures | $1,321,315 | 70.9% |
| 2 | Procedures / Professional Services | $482,608 | 25.9% |
| 3 | Evaluation and Management | $35,962 | 1.9% |
| 4 | Medicine Services and Procedures | $21,012 | 1.1% |
| 5 | Surgery | $2,740 | 0.1% |
| 6 | Radiology Procedures | $919 | <0.1% |
| 7 | Temporary Codes | $140 | <0.1% |
| 8 | Diagnostic Radiology Services | $0 | <0.1% |
| 8 | Drugs Administered Other than Oral Method | $0 | <0.1% |
| 8 | Medical And Surgical Supplies | $0 | <0.1% |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 80307 | Drug test prsmv chem anlyzr | $453,841 | 12 |
| 86480 | Tb test cell immun measure | $94,662 | 12 |
| 83992 | Assay for phencyclidine | $35,102 | 9 |
| 87491 | Chlmyd trach dna amp probe | $27,312 | 12 |
| 83655 | Assay of lead | $26,151 | 12 |
| 87591 | N.gonorrhoeae dna amp prob | $24,544 | 12 |
| 80323 | Alkaloids nos | $24,242 | 9 |
| 87389 | Hiv-1 ag w/hiv-1&-2 ab ag ia | $23,526 | 12 |
| 82652 | Vit d 1 25-dihydroxy | $23,502 | 12 |
| 80375 | Drug/substance nos 1-3 | $22,297 | 9 |
| 80053 | Comprehen metabolic panel | $22,159 | 13 |
| 80348 | Drug screening buprenorphine | $20,050 | 9 |
| 80364 | Opioid &opiate analog 5/more | $18,343 | 9 |
| 80354 | Drug screening fentanyl | $17,777 | 9 |
| 80373 | Drug screening tramadol | $17,435 | 9 |
| 80372 | Drug screening tapentadol | $17,205 | 9 |
| 80349 | Cannabinoids natural | $17,012 | 9 |
| 87631 | Resp virus 3-5 targets | $16,290 | 7 |
| 80371 | Stimulants synthetic | $15,669 | 9 |
| 80324 | Drug screen amphetamines 1/2 | $15,485 | 9 |
Note: HCPCS codes are shown for context within the category. Category totals and rankings in this article are based on standardized service groupings rather than individual billing codes.
Information in this article was obtained from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The source data can be found here.









